In symptomatic COPD, once-daily triple vs dual therapy reduced moderate or severe exacerbations at 1 year
- PMID: 30128506
- DOI: 10.7326/ACPJC-2018-169-4-016
In symptomatic COPD, once-daily triple vs dual therapy reduced moderate or severe exacerbations at 1 year
Comment on
-
Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD.N Engl J Med. 2018 May 3;378(18):1671-1680. doi: 10.1056/NEJMoa1713901. Epub 2018 Apr 18. N Engl J Med. 2018. PMID: 29668352 Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical